Charles Swingland brings 30 years of corporate legal experience to PsiOxus. He was Executive Director, General Counsel and Company Secretary at PowderJect Pharmaceuticals Plc from 1996 to 2003. At PowderJect Charles was responsible for all legal, intellectual property and compliance matters and managed the legal aspects of several major acquisitions and fundraisings, including the eventual sale of the company to Chiron for $1 billion. In 2004, he joined Zeneus Pharma as a Director and General Counsel, where he oversaw the company’s transactions, including the in-licensing of several products and its sale to Cephalon Inc. Charles subsequently established Circassia with Steve Harris in 2007, where he is Deputy Chairman and General Council. Before joining industry, Charles practised as a corporate lawyer in the City of London for over 15 years.